Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


FDA oncological drugs advisory committee votes in support of Tecentriq in bladder cancer – Genentech/Roche

Written by | 4 May 2021

Genentech/Roche announced the FDA Oncologic Drugs Advisory Committee voted 10 to 1 in favor of maintaining accelerated approval of Tecentriq (atezolizumab) for the treatment of adults with locally… read more.

FDA approves Xolair prefilled syringe for self-injection across all indications – Genentech + Novartis

Written by | 24 Apr 2021

Genentech, a member of the Roche Group announced that the FDA has approved the company’s supplemental Biologics License Application for Xolair (omalizumab) prefilled syringe for self-injection across all… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.